By Michele Maatouk
Date: Thursday 16 Jun 2022
LONDON (ShareCast) - (Sharecast News) - Barclays upgraded Victrex on Thursday and downgraded Synthomer as it took a look at European chemical stocks.
Victrex was upgraded to 'overweight' from 'equalweight' and the price target was lifted to 2,200p from 2,060p.
Synthomer was downgraded to 'equalweight' from 'overweight' and the price target cut to 323p from 420p.
Barclays said Victrex should have outperformed other cyclical chemical stocks this year given its relative resilience in a recession, but instead it has materially underperformed.
Meanwhile, it noted that Synthomer is "one of the more vulnerable stocks" and said it was downgrading despite the recent re-rating.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 255.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 936.22p |
52 Week Low | 122.50p |
Volume | 4,522 |
Shares Issued | 163.57m |
Market Cap | £417.10m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | n/a | 01-Jun-22 |
Paid | n/a | 05-Jul-22 |
Amount | 0.000p | 21.30p |
Time | Volume / Share Price |
11:41 | 411 @ 251.76p |
09:37 | 544 @ 253.73p |
09:08 | 1,563 @ 252.41p |
08:51 | 1,500 @ 252.41p |
08:08 | 504 @ 256.50p |
You are here: research